Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.
Those who microdose psychedelics report improved mood, greater focus, and increased creativity. A new study looks at the positive outcomes of microdosing and suggests others look at potential long-term negative consequences of using psychedelics.
While many people report microdosing is beneficial to their mental wellbeing, researchers say more research needs to be conducted to evaluate the psychological and health implications of taking low-dose psychedelics.
Microdosing, a growing trend where people take small doses for psychedelic drugs, is associated with improved mood, focus, and creativity. For some, microdosing may provide a possible alternative to SSRI antidepressants. However, researchers warn of some potential problems with microdosing, including negative side effects, psychological stigma, and exposure to elicit, black market products.
A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing.
Researchers report LSD triggers a reduction in functional connection between areas of the brain that govern cognitive processes, while increasing connectivity in brain networks associated with sensory functions.
Researchers explore why using hallucinogens to treat an array of mental health disorders is becoming more popular.
Researchers explore the potential benefits of using hallucinogens for the treatment of PTSD, anxiety, depression and other mental health disorders.
A new study reveals psychedelics increase dendrites, dendritic spines and synapses, while ketamine may promote neuroplasticity. The findings could help develop new treatments for anxiety, depression and other related disorders.
Men who have prior experience with psychedelic drugs have a reduced likelihood of engaging in violence against their partner, a new study reports.
A new study reports people who have used a classic psychedelic are significantly less likely to commit a crime or indulge in criminal behavior. However, use of other controlled substances is linked to an increased risk of criminal behavior, researchers report.